Anti-counterfeit technology has emerged as a preferred choice of solution against cases of counterfeiting. The market is expected to witness a remarkable growth, chiefly due to increasing instances of electronic/automobile counterfeit products, which are easily available in the local markets.
The global anti-counterfeit (electronics and automobiles) market is expected to reach $24.2 billion by 2020, at a notable CAGR of 10.1% from 2015 to 2020. Advanced technology in tracking, and adoption of item level RFID technologies are the major factors that drive the market growth. Other factors responsible for the market growth are rising awareness of the consumers about anti-counterfeit technologies and rising government regulations and efforts laid on eradicating the electronic counterfeit products in various developed and developing nations. On the other hand, high cost associated with implementation of product identification (anti-counterfeit) setups and impact of anti-counterfeit products on product distribution process are likely to restrain the market growth.
Multiple applications of track and trace technologies, advancements in item level RFID such as (FiTS) technology would offer lucrative growth opportunities in future. Further, the collaborative approach of various companies with government authorities would provide a platform for growth of the global anti-counterfeit packaging (electronics and automobiles) market.
To provide a detailed market assessment, the report segments the global anti-counterfeit (electronics and automobiles) market on the basis of technology and geography. The technology segment market is categorized into ink & dyes, holograms, watermarks, taggants, and track and trace packaging technologies. Inks & dyes and holograms were the leading technology segments, collectively accounting for around three-fourths of the market in 2014.
Geographically, the market is segmented across North America, Europe, Asia Pacific and LAMEA. In 2014, North America was the largest revenue generating region with annual revenue of share of 43%, followed by Europe. The Asia-Pacific anti-counterfeit packaging (electronics and automobiles) market is set to grow at a promising CAGR of 11.1% from 2015 to 2020, due to rising awareness about anti-counterfeit technologies penetrating regional-markets.
KEY MARKET BENEFITS:
The report provides the quantitative analysis of the current market and estimations through 2014-2020 that assists in identifying the prevailing market opportunities to capitalize on
The report helps in understanding the strategies adopted by various key market players, in order to gain a higher market share in the global anti-counterfeit packaging (electronics and automobiles) market
Country-wise in the global anti-counterfeit packaging (electronics and automobiles) market are comprehensively analyzed in the report
The projections in the report are made by analyzing the current market trends and highlighting the market potential for the period of 2014-2020, in terms of value
Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework
SWOT analysis of the key market players is provided to illustrate the business strategies adopted by the companies
KEY MARKET SEGMENTS:
The global anti-counterfeit packaging (electronics and automobiles) market is segmented on the basis of technology and geography:
Global anti-counterfeit packaging (electronics and automobiles) Market By Technology
Inks & Dyes
Track and trace packing technologies
Global anti-counterfeit packaging (electronics and automobiles) Market By Geography
SIMILAR MARKET STUDIES
DNA sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-Time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017-2023
DNA sequencing is a molecular technique, which help to determine the nucleotide sequence of DNA (deoxyribonucleic acid), which is the most fundamental level of knowledge of a gene or genome. The global DNA sequencing market accounted for $5,156 million in 2016, and is anticipated to reach $18,284 million by 2023, ...
May 2017 | $5370 | View Details >>
Nerve Repair and Regeneration Market by Surgery [Direct Neuropathy by Type (Epineural Repair, Perineural Repair, and Group Fascicular Repair), Nerve Grafting by Type (Autografts, Allografts, and Xenografts), Neuromodulation Surgery (External and Internal), and Stem Cell Therapy] and Product [Biomaterial by Type (Nerve Conduits, Nerve Protectors, Nerve Wraps, and Nerve Connectors) and Neuromodulation Surgery Devices by Type (External by Type (Transcutaneous Electrical Nerve Stimulation and Transcranial Magnetic Stimulation) and Internal by Type (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, and Others)]: Global Opportunity Analysis and Industry Forecast, 2017-2023
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early diagnosis and treatment can prevent complications and permanent injuries. The techniques of nerve repair and regeneration aid to cure the disorders such Alzheimerâ€™s disease, Parkinson disease, and other neurological disorders.
May 2017 | $5370 | View Details >>
Malaysia Intravenous Immunoglobulin (IVIG) Market by Product Types (IgG, IgA, IgM, IgE and IgD), Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Immune Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-BarrÃ© Syndrome, Kawasaki Disease, Secondary Immune Deficiency, And Other Applications), Mode of Delivery (Intravenous, Intramuscular, Subcutaneous), and Concentration (5%, 10% and Other Concentration): Opportunity Analysis and Industry Forecast, 2014-2022
Intravenous immunoglobulin (IVIG) is a blood/plasma product, which is prepared from the serum of multiple of donors, used to treat patients with antibody deficiency. The isolated plasma product is clinically treated and purified to Ig, which further facilitates the treatment. IVIG is applicable in various fields such as hematology, immunology, neurology, dermatology, nephrology, ophthalmology, and rheumatology.
May 2017 | $2850 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research